A comprehensive atlas of pediatric immune checkpoint inhibitors‐related adverse events: From real‐world pharmacovigilance data to mechanistic insights
Abstract Background Immune checkpoint inhibitors (ICIs) are widely used in childhood cancer, posing challenges with associated ICIs‐related adverse events (irAEs). This study focuses on pediatric irAEs and explores underlying mechanisms. Methods Data on ICI‐related adverse reactions were gathered fr...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wiley
2025-10-01
|
| Edice: | Clinical and Translational Discovery |
| Témata: | |
| On-line přístup: | https://doi.org/10.1002/ctd2.70086 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
